Multiple congressional inquiries have focused on insulin, and on Tuesday, a subcommittee of the House Energy and Commerce Committee held a hearing on insulin prices that featured testimony from patients and doctors. Executives from the top pharmacy benefit managers, including Express Scripts, are scheduled to testify before the Senate Finance Committee next week, when the price of insulin will also likely come up. “For people with diabetes, insulin can be as essential as air,” said Dr. Steve Miller, the executive vice president and chief clinical officer of Cigna, which merged last year with Express Scripts. | Sign up for the Science Times newsletter.] Cigna and Express Scripts said the average out-of-pocket cost for consumers under their existing plans was $41.50 for a 30-day supply of insulin.

Source: New York Times April 03, 2019 10:30 UTC